News & Updates

Tranexamic acid of no help in reducing bleeding complications related to HoLEP

14 Jul 2023

Perioperative tranexamic acid treatment in patients undergoing holmium laser enucleation of the prostate (HoLEP) falls short of reducing the risk of a return to the operating room for bleeding, catheter reinsertion, or clotting complications, according to a study.

Tranexamic acid of no help in reducing bleeding complications related to HoLEP

14 Jul 2023

PNH carries a high disease burden despite treatment

14 Jul 2023 by

Paroxysmal nocturnal haemoglobinuria (PNH) carries a substantial disease burden and healthcare resource utilization, even in patients already receiving treatment with C5 inhibitors, according to an expert who presented at EHA 2023.

PNH carries a high disease burden despite treatment

14 Jul 2023

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

04 Jul 2023

The periconceptional use of methotrexate among men does not contribute to an increase in the risk of congenital anomalies, preterm birth (PTB), and being small for gestational age (SGA), but it may lead to a temporary decrease in fertility, according to a study.

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

04 Jul 2023

Individuals with overactive bladder sleep poorly

03 Jul 2023

Sleep disturbance appears to be common among individuals with overactive bladder (OAB), regardless of treatment, as reported in a study.

Individuals with overactive bladder sleep poorly

03 Jul 2023

Artificial urinary sphincter erosion linked to history of pelvic radiation

03 Jul 2023

A recent study has shown that artificial urinary sphincter cuff erosion neither causes urethral stricture formation nor contributes to a degree of erosion.

Artificial urinary sphincter erosion linked to history of pelvic radiation

03 Jul 2023

Focal therapy an effective option for older, comorbid prostate cancer patients

02 Jul 2023

Focal ablative therapy may be used as an alternative treatment for older or comorbid patients with prostate cancer who are not fit or willing to undergo radical treatment, suggests a study.

Focal therapy an effective option for older, comorbid prostate cancer patients

02 Jul 2023

Renal mass biopsy mandate tied to fewer surgeries, greater surveillance

30 Jun 2023

Implementation of the mandate on preablation renal mass biopsy appears to result in the wider use of biopsies for all small renal mass patients, fewer surgical interventions, and an increase in active surveillance, reports a recent study.

Renal mass biopsy mandate tied to fewer surgeries, greater surveillance

30 Jun 2023

Erdafitinib prevails in bladder cancer with select FGFRalt

22 Jun 2023 by

The oral selective pan-FGFR tyrosine kinase inhibitor (TKI) erdafitinib demonstrated a survival advantage over chemotherapy, extending multiple efficacy endpoints in individuals with advanced or metastatic urothelial carcinoma (mUC) with FGFR alterations (FGFRalt) after previous anti-PD-(L)1 treatment, findings from the confirmatory phase III THOR trial have shown.

Erdafitinib prevails in bladder cancer with select FGFRalt

22 Jun 2023

Methotrexate poses no risk for men seeking parenthood

13 Jun 2023 by

Treatment with methotrexate (MTX) does not appear to be associated with testicular toxicity, according to the results of the iFAME-MTX study, dispelling concerns about the effect of the drugs among men wishing to become a parent and their clinicians.

Methotrexate poses no risk for men seeking parenthood

13 Jun 2023

Organ sparing may predispose genitourinary rhabdomyosarcoma patients to extra surgery

06 Jun 2023

Patients with genitourinary rhabdomyosarcoma who undergo organ-sparing treatment have higher odds of additional reconstructive surgery due to compromised urological function, reports a study.

Organ sparing may predispose genitourinary rhabdomyosarcoma patients to extra surgery

06 Jun 2023

News & Updates

Filter by Specialty:

Specialty:

Tranexamic acid of no help in reducing bleeding complications related to HoLEP

Tranexamic acid of no help in reducing bleeding complications related to HoLEP

PNH carries a high disease burden despite treatment

PNH carries a high disease burden despite treatment

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

Paternal methotrexate use confers no teratogenic effects but may temporarily reduce fertility

Individuals with overactive bladder sleep poorly

Individuals with overactive bladder sleep poorly

Artificial urinary sphincter erosion linked to history of pelvic radiation

Artificial urinary sphincter erosion linked to history of pelvic radiation

Focal therapy an effective option for older, comorbid prostate cancer patients

Focal therapy an effective option for older, comorbid prostate cancer patients

Renal mass biopsy mandate tied to fewer surgeries, greater surveillance

Renal mass biopsy mandate tied to fewer surgeries, greater surveillance

Erdafitinib prevails in bladder cancer with select FGFRalt

Erdafitinib prevails in bladder cancer with select FGFRalt

Methotrexate poses no risk for men seeking parenthood

Methotrexate poses no risk for men seeking parenthood

Organ sparing may predispose genitourinary rhabdomyosarcoma patients to extra surgery

Organ sparing may predispose genitourinary rhabdomyosarcoma patients to extra surgery